Covid-19 roundup: Re­gen­eron/Roche an­ti­body com­bo keeps its punch 8 months in; WaPo: Pfiz­er ex­pect­ed to seek au­tho­riza­tion for boost­ers for all adults

Push­ing hard to carve out a block­buster mar­ket ahead of the grow­ing com­pe­ti­tion among an­ti-Covid treat­ments, re­searchers from Re­gen­eron and Roche are tout­ing new da­ta …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER